97 related articles for article (PubMed ID: 33723131)
21. Strong association of interleukin-6 -174G/C promoter single nucleotide polymorphism with a decreased risk of colorectal cancer in ethnic Kashmiri population: A case control study.
Banday MZ; Balkhi HM; Sameer AS; Chowdri NA; Haq E
Tumour Biol; 2017 Mar; 39(3):1010428317695940. PubMed ID: 28349833
[TBL] [Abstract][Full Text] [Related]
22. A two-gene blood test for methylated DNA sensitive for colorectal cancer.
Pedersen SK; Baker RT; McEvoy A; Murray DH; Thomas M; Molloy PL; Mitchell S; Lockett T; Young GP; LaPointe LC
PLoS One; 2015; 10(4):e0125041. PubMed ID: 25928810
[TBL] [Abstract][Full Text] [Related]
23. Association between MLH1 -93G>a polymorphism and risk of colorectal cancer.
Wang T; Liu Y; Sima L; Shi L; Wang Z; Ni C; Zhang Z; Wang M
PLoS One; 2012; 7(11):e50449. PubMed ID: 23226285
[TBL] [Abstract][Full Text] [Related]
24. IKAROS Family Zinc Finger 1-Associated Diseases in Primary Immunodeficiency Patients.
Nunes-Santos CJ; Kuehn HS; Rosenzweig SD
Immunol Allergy Clin North Am; 2020 Aug; 40(3):461-470. PubMed ID: 32654692
[TBL] [Abstract][Full Text] [Related]
25. Pri-miR-124 rs531564 polymorphism and colorectal cancer risk.
Gao XR; Wang HP; Zhang SL; Wang MX; Zhu ZS
Sci Rep; 2015 Oct; 5():14818. PubMed ID: 26423518
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-10 -592C/A, but not -1082A/G promoter single nucleotide polymorphism, is associated with a decreased risk of colorectal cancer in an ethnic Kashmiri population: a case-control study.
Banday MZ; Sameer AS; Chowdri NA; Haq E
Eur J Cancer Prev; 2017 Nov; 26(6):476-490. PubMed ID: 28538040
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of an assay for methylated BCAT1 and IKZF1 in plasma for detection of colorectal neoplasia.
Pedersen SK; Symonds EL; Baker RT; Murray DH; McEvoy A; Van Doorn SC; Mundt MW; Cole SR; Gopalsamy G; Mangira D; LaPointe LC; Dekker E; Young GP
BMC Cancer; 2015 Oct; 15():654. PubMed ID: 26445409
[TBL] [Abstract][Full Text] [Related]
28. A MLH1 polymorphism that increases cancer risk is associated with better outcome in sporadic colorectal cancer.
Nejda N; Iglesias D; Moreno Azcoita M; Medina Arana V; González-Aguilera JJ; Fernández-Peralta AM
Cancer Genet Cytogenet; 2009 Sep; 193(2):71-7. PubMed ID: 19665066
[TBL] [Abstract][Full Text] [Related]
29. Assessing the Functional Relevance of Variants in the
Eskandarian Z; Fliegauf M; Bulashevska A; Proietti M; Hague R; Smulski CR; Schubert D; Warnatz K; Grimbacher B
Front Immunol; 2019; 10():568. PubMed ID: 31057532
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms of tumor necrosis factor alpha in Middle Eastern population with colorectal cancer.
Hamadien MA; Khan Z; Vaali-Mohammed MA; Zubaidi A; Al-Khayal K; McKerrow J; Al-Obeed O
Tumour Biol; 2016 Apr; 37(4):5529-37. PubMed ID: 26572151
[TBL] [Abstract][Full Text] [Related]
31. Phenotypic and tumor molecular characterization of colorectal cancer in relation to a susceptibility SMAD7 variant associated with survival.
Garcia-Albeniz X; Nan H; Valeri L; Morikawa T; Kuchiba A; Phipps AI; Hutter CM; Peters U; Newcomb PA; Fuchs CS; Giovannucci EL; Ogino S; Chan AT
Carcinogenesis; 2013 Feb; 34(2):292-8. PubMed ID: 23104301
[TBL] [Abstract][Full Text] [Related]
32. IKAROS-Associated Diseases in 2020: Genotypes, Phenotypes, and Outcomes in Primary Immune Deficiency/Inborn Errors of Immunity.
Kuehn HS; Nunes-Santos CJ; Rosenzweig SD
J Clin Immunol; 2021 Jan; 41(1):1-10. PubMed ID: 33392855
[TBL] [Abstract][Full Text] [Related]
33. Association of PARK2 promoter polymorphisms and methylation with colorectal cancer in North Indian population.
Bhat ZI; Kumar B; Bansal S; Naseem A; Tiwari RR; Wahabi K; Sharma GD; Alam Rizvi MM
Gene; 2019 Jan; 682():25-32. PubMed ID: 30296568
[TBL] [Abstract][Full Text] [Related]
34. A cross-sectional study comparing a blood test for methylated BCAT1 and IKZF1 tumor-derived DNA with CEA for detection of recurrent colorectal cancer.
Young GP; Pedersen SK; Mansfield S; Murray DH; Baker RT; Rabbitt P; Byrne S; Bambacas L; Hollington P; Symonds EL
Cancer Med; 2016 Oct; 5(10):2763-2772. PubMed ID: 27726312
[TBL] [Abstract][Full Text] [Related]
35. IKZF1 rs4132601 and rs11978267 Gene Polymorphisms and Acute Lymphoblastic Leukemia: Relation to Disease Susceptibility and Outcome.
Mosaad YM; El-Ziny MA; Darwish A; Al-Harrass M; Abdmabood S; Fawzy IM; Sherif DM; Yakoub MG; Abdeltawab H
J Pediatr Hematol Oncol; 2020 Oct; 42(7):420-428. PubMed ID: 32769565
[TBL] [Abstract][Full Text] [Related]
36. Association of newly identified genetic variant rs2853677 of TERT with non-small cell lung cancer and leukemia in population of Jammu and Kashmir, India.
Bhat GR; Bhat A; Verma S; Sethi I; Shah R; Sharma V; Dar KA; Abrol D; Kaneez S; Kaul S; Ganju R; Kumar R
BMC Cancer; 2019 May; 19(1):493. PubMed ID: 31126249
[TBL] [Abstract][Full Text] [Related]
37. The
Li J; Zhu Y; Zhou Y; Jiang H; Chen Z; Lu B; Shen X
Genet Test Mol Biomarkers; 2020 Dec; 24(12):835-844. PubMed ID: 33290140
[No Abstract] [Full Text] [Related]
38. TP53 Arg 72Pro and MDM2 SNP309 polymorphisms and colorectal cancer risk: a west Algerian population study.
Abderrahmane R; Louhibi L; Moghtit FZ; Boubekeur A; Benseddik K; Boudjema A; Benrrahal F; Aberkane M; Fodil M; Saidi-Mehtar N
Pathol Oncol Res; 2015 Jul; 21(3):629-35. PubMed ID: 25537146
[TBL] [Abstract][Full Text] [Related]
39. Role of the VDR Bsm I and Apa I polymorphisms in the risk of colorectal cancer in Kashmir.
Rasool S; Kadla SA; Rasool V; Qazi F; Khan T; Shah NA; Ganai BA
Oncol Res Treat; 2014; 37(6):345-9. PubMed ID: 24903766
[TBL] [Abstract][Full Text] [Related]
40. The association of CTLA-4 A49G polymorphism with colorectal cancer risk in a Chinese Han population.
Wang Y; Wang X; Zhao R
Int J Immunogenet; 2015 Apr; 42(2):93-9. PubMed ID: 25689638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
